Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670127 | SCV000794944 | pathogenic | Xeroderma pigmentosum, group C | 2017-10-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002531245 | SCV003525114 | pathogenic | not provided | 2023-12-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg293*) in the XPC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XPC are known to be pathogenic (PMID: 23173980, 25256075). This variant is present in population databases (rs373519125, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum (PMID: 26884178). ClinVar contains an entry for this variant (Variation ID: 554485). For these reasons, this variant has been classified as Pathogenic. |
Division of Human Genetics, |
RCV003403557 | SCV004123088 | pathogenic | Xeroderma pigmentosum | 2023-07-01 | criteria provided, single submitter | research | |
Baylor Genetics | RCV000670127 | SCV004206976 | pathogenic | Xeroderma pigmentosum, group C | 2024-02-20 | criteria provided, single submitter | clinical testing |